Tamara Tyrinova

Dr. Tamara Tyrinova

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Cytokine
Verified
Journal Article
Closed access
OLOlga Yu. Leplina
Olga Yu. Leplina
TTTamara Tyrinova
Tamara Tyrinova
MTMarina A. Tikhonova
Marina A. Tikhonova
AOAlexander A. Ostanin
Alexander A. Ostanin
ECElena R. Chernykh
Elena R. Chernykh

16 February 2024 in Heliyon
Verified
Journal Article
Open access
TTTamara Tyrinova
Tamara Tyrinova
EBEgor Batorov
Egor Batorov
TATatyana Aristova
Tatyana Aristova
GUGalina Ushakova
Galina Ushakova
SSSvetlana Sizikova
Svetlana Sizikova
ECElena Chernykh
Elena Chernykh
Recent studies demonstrated that myeloid-derived suppressor cells (MDSCs) are involved in the pathogenesis and progression of multiple myeloma (MM). Nevertheless, data on the quantitative and functional changes in MDSCs during standard MM treatment remain poorly understood. Here, we determined that monocytic MDSCs (M-MDSC; CD14+HLA-DRlow/–) and granulocytic MDSCs (PMN-MDSC; Lin–HLA-DR–CD33+CD66b+) in MM patients in remission following induction therapy (IT) were significantly increased, while early MDSCs (E-MDSCs; Lin–HLA-DR–CD33+CD66b–) were decreased compared to the donor group. In progression, MM patients had the most pronounced decrease in E-MDSCs and enhanced levels of PMN-MDSCs. IT was accompanied with a decrease in the expression of arginase-1 (Arg-1). In MM patients with relapse or resistance to IT, Arg-1+ cell frequency in M-MDSCs and E-MDSCs, as well as PD-L1+ M-MDSCs, was increased, which may facilitate tumor immunosuppression. G-CSF administration led to a significant increment in the MDSC subsets. At the engraftment, circulating M-MDSC and PMN-MDSCs were temporarily increased, with a gradual decline to the pre-transplant levels in 12 months. The percentage of E-MDSCs was decreased at the leukocyte recovery. Patients with a higher (>Me) M-MDSC count at the engraftment had a shorter post-transplant leukopenia duration (Me 11 vs. 13 days; pU = 0.0086). The advanced MM stage, depth of response, and lower relative count of circulating E-MDSCs at the engraftment were independent risk factors associated with a lower progression-free survival.

1 July 2013 in Cellular Immunology
Verified
Journal Article
Closed access
TTTamara Tyrinova
Tamara Tyrinova
OLOlga Yu. Leplina
Olga Yu. Leplina
SMSergey Mishinov
Sergey Mishinov
MTMarina A. Tikhonova
Marina A. Tikhonova
ESEkaterina Ya. Shevela
Ekaterina Ya. Shevela
ECElena R. Chernykh
Elena R. Chernykh

28 November 2022 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
TTTamara Tyrinova
Tamara Tyrinova
EBE. V. Batorov
E. V. Batorov
TAT. A. Aristova
T. A. Aristova
GUG. Yu. Ushakova
G. Yu. Ushakova
SSS. A. Sizikova
S. A. Sizikova
ECE. R. Chernykh
E. R. Chernykh

1 July 2009 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
OLOlga Leplina
Olga Leplina
MTM. A. Tikhonova
M. A. Tikhonova
LSL. V. Sakchno
L. V. Sakchno
TTTamara Tyrinova
Tamara Tyrinova
AOAlexander Ostanin
Alexander Ostanin
ECE. R. Chernykh
E. R. Chernykh

Verified
Journal Article
Open access
PDF file
TTTamara Tyrinova
Tamara Tyrinova
OLOlga Leplina
Olga Leplina
SMSergey Mishinov
Sergey Mishinov
MTMarina Tikhonova
Marina Tikhonova
EDEvgeniya V. Dolgova
Evgeniya V. Dolgova
ECElena Chernykh
Elena Chernykh
Besides an antigen-presenting function and ability to induce antitumor immune responses, dendritic cells (DCs) possess a direct tumoricidal activity. We previously reported that monocyte-derived IFNα-induced DCs (IFN-DCs) of glioblastoma multiforme patients express low levels of membrane TNFα molecule (mTNFα) and have impaired TNFα/TNF-R1-mediated cytotoxicity against immortalized tumor cell line HEp-2. However, whether the observed defect could affect killer activity of glioma patient DCs against autologous tumor cells remained unclear. Here, we show that donor IFN-DCs possess cytotoxic activity against glioblastoma cell lines derived from a primary tumor culture. Granule-mediated and TNFα/TNF-R1-dependent pathways were established as the main mechanisms underlying cytotoxic activity of IFN-DCs. Glioblastoma patient IFN-DCs showed lower cytotoxicity against autologous glioblastoma cells sensitive to TNFα/TNFR1-mediated lysis, which was associated with low TNFα mRNA expression and high TACE/ADAM-17 enzyme activity. Recombinant IL-2 (rIL-2) and human double-stranded DNA (dsDNA) increased 1.5-fold cytotoxic activity of patient IFN-DCs against autologous glioblastoma cells. dsDNA, but not rIL-2, enhanced the expression of TNFα mRNA and decreased expression and activity of TACE/ADAM-17 enzyme. In addition, dsDNA and rIL-2 stimulated the expression of perforin and granzyme B (in the presence of dsDNA), suggesting the possibility of enhancing DC cytotoxicity against autologous glioblastoma cells via various mechanisms.